Alkeus Pharmaceuticals announced positive interim data from its TEASE-3 Stargardt disease study. Two additional participants who completed 24 months...

IO Biotech has completed enrollment in its Phase 2 basket trial, IOB-032/PN-E40, ahead of schedule. The trial evaluates the...

Acumen Pharmaceuticals announced positive Phase 1 clinical trial results for sabirnetug (ACU193), a potential Alzheimer’s diseaseAlzheimer’s disease treatment targeting...

Alleviant Medical received FDA approval to begin a pivotal trial of its no-implant atrial shunt for heart failure patients...

Sana Biotechnology announced positive initial results from a first-in-human study involving a patient with type 1 diabetes. The study,...

MAIA Biotechnology will collaborate with BeiGene to evaluate THIO, MAIA’s telomere-targeting anticancer drug, in combination with BeiGene’s immune checkpoint...

The global retinal gene therapy market is projected to exceed US$110 million in revenue in 2024, driven by the...

BioSkryb Genomics launched ResolveSEQ MRD, a service that enhances the analysis of minimal residual disease (MRD) in hematological malignancies....

Tenvie Therapeutics launched with $200 million in funding to develop small molecule treatments for neurological diseases. The company acquired...

The sales of the top 20 drugs targeting molecular switches have exceeded $30 billion, highlighting the growing importance of...